Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 8.04% of ...
PiperSandler analyst Joseph Catanzaro maintained a Hold rating on Iovance Biotherapeutics (IOVA – Research Report) today and set a price target of $10.00. The company’s shares closed yesterday at ...
On Tuesday, Berry Corporation (Bry) (BRY) stock saw a decline, ending the day at $5.12 which represents a decrease of $-0.24 or -4.48% from the prior close of $5.36. The stock opened at $5.21 and ...